Mark Pegram, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Topic:
    Consultant
    Date added:
    04/07/2022
    Date updated:
    01/08/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Gilead
    Topic:
    Consultant
    Date added:
    04/10/2023
    Date updated:
    01/08/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Employment
    Ineligible company:
    Rain Oncology
    Topic:
    Drug Development
    Date added:
    04/10/2023
    Date updated:
    01/08/2024
    Relationship end date:
    12/31/2023
Return to Summit on Cancer Health Disparities (SCHD24)